A graphene sensor is expanding molecular detection for healthcare, agriculture, environmental testing, chemical analysis, and industrial monitoring.
Graphene electronics company Paragraf has expanded its Graphene Field Effect Transistor (GFET) product line with the introduction of the PMF2000 GFET, a new graphene-based sensor designed for molecular sensing applications at industrial scale.
Researchers, diagnostic developers, sensor manufacturers, and companies working in healthcare, agritech, chemical analysis, and industrial monitoring can use the PMF2000 to develop sensors capable of detecting and measuring molecules, chemicals, and biological materials. The device is intended for applications such as disease detection, environmental monitoring, agricultural testing, chemical analysis, and industrial process monitoring.
The PMF2000 is the first device to be manufactured at Paragraf’s new large-wafer production facility in Huntingdon, described by the company as the world’s first graphene foundry. The facility is designed to increase device yield and improve manufacturing consistency, enabling customers to order larger volumes of sensors while maintaining reliable and repeatable performance.
According to the company, the new production capability allows the PMF2000 to deliver consistent results at high volumes without requiring changes to the chip’s design or function. The foundry also provides the flexibility to produce customized sensor designs configured for specific sensing applications.
The device features a pristine, contamination-free graphene layer on silicon and is aimed at customers developing molecular sensing systems. Existing users of Paragraf’s original GFET devices can transition to the PMF2000 without modifying their current designs while benefiting from increased supply capacity.
‘The PMF2000 GFET’s graphene-on-silicon construction represents the strongest demonstration yet that Paragraf’s proprietary graphene technology has unlocked the future of increased performance semiconductor production,’ said Dr. Simon Thomas, Co-Founder and CEO of Paragraf. ‘We look forward to seeing our customers use this device to break new ground in healthcare, agritech, chemical and industrial applications.’
Click here for the original announcement.
